What is the diagnosis and management for a patient with Acute Kidney Injury (AKI) with a Fractional Excretion of Sodium (FeNa) of 0.8%, Blood Urea Nitrogen (BUN) of 57, and creatinine of 3.36?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Prerenal Acute Kidney Injury

Based on your FeNa of 0.8%, BUN:Cr ratio of 17:1, and elevated creatinine, this presentation is most consistent with prerenal AKI (volume depletion or decreased effective arterial blood volume), though the FeNa is borderline and requires careful clinical correlation. 1, 2

Interpretation of Laboratory Values

FeNa Analysis

  • Your FeNa of 0.8% falls just below the traditional 1% cutoff for prerenal AKI 1, 2
  • FeNa <1% suggests prerenal causes including volume depletion, with the kidney appropriately conserving sodium in response to decreased perfusion 1, 2
  • However, FeNa has important limitations: in cirrhosis, FeNa <1% has 100% sensitivity but only 14% specificity for prerenal causes, meaning many patients with intrinsic kidney disease can also have low FeNa 1
  • If the patient has received diuretics, FeNa becomes unreliable - diuretics increase urinary sodium excretion and can falsely elevate FeNa even in prerenal states 3, 4

BUN:Creatinine Ratio

  • Your BUN:Cr ratio of 17:1 (57÷3.36) is at the lower end of what typically suggests prerenal azotemia 2
  • Classic prerenal AKI usually shows BUN:Cr ratio >20:1, though this can be affected by protein intake, GI bleeding, and catabolic states 2
  • The relatively modest elevation suggests either early prerenal AKI or a mixed picture 2

Consider Fractional Excretion of Urea (FEUrea)

  • FEUrea is superior to FeNa if diuretics have been administered 3, 4
  • FEUrea <35% indicates prerenal AKI with 89% sensitivity in diuretic-treated patients, compared to only 48% for FeNa <1% 3
  • FEUrea remains low in prerenal states (typically 25-28%) regardless of diuretic use, while it rises to >50% in acute tubular necrosis 3, 4
  • If diuretics were given, obtain FEUrea immediately to clarify the diagnosis 3, 4

Differential Diagnosis Based on Your Values

Most Likely: Prerenal AKI (Volume Depletion)

  • FeNa 0.8% supports this, though borderline 1, 2
  • Look for: recent diuretic use, poor oral intake, vomiting, diarrhea, hemorrhage, third-spacing (cirrhosis, heart failure, sepsis) 1
  • Should respond to volume expansion with return of creatinine to within 0.3 mg/dL of baseline 1

Alternative: Early Acute Tubular Necrosis (ATN)

  • Low FeNa can occur in early ATN if tested within 1-2 days of onset - 39% of ATN patients have FeNa <1% when tested early 5
  • FeNa typically converts to >1% on repeat testing as ATN evolves 5
  • Look for: nephrotoxin exposure (NSAIDs, aminoglycosides, contrast), prolonged hypotension, sepsis 6
  • Urine microscopy showing muddy brown casts or renal tubular epithelial cells strongly suggests ATN 6

Consider: Hepatorenal Syndrome (if cirrhosis present)

  • HRS-AKI typically shows FeNa <1% but FeNa has very poor specificity (14%) in cirrhotic patients 1
  • FEUrea <28% has better discrimination (75% sensitivity, 83% specificity) for HRS versus non-HRS causes 1
  • Requires exclusion of volume depletion, nephrotoxins, and structural kidney disease 1

Immediate Management Algorithm

Step 1: Remove Risk Factors (All AKI Patients)

  • Withdraw all nephrotoxic drugs immediately: NSAIDs, ACE inhibitors, ARBs, aminoglycosides, contrast agents 1
  • Hold or reduce diuretics 1
  • Review all medications including over-the-counter drugs 1

Step 2: Assess Volume Status and Expand if Indicated

  • If clinical hypovolemia suspected, give albumin 1 g/kg/day (maximum 100 g/day) for 2 consecutive days 1
  • Alternative: crystalloids or blood products if hemorrhage present 1
  • Monitor carefully for volume overload and pulmonary edema - this is a critical complication of albumin therapy 1

Step 3: Rule Out Infection

  • Obtain cultures (blood, urine) and chest X-ray 1
  • If cirrhosis: perform diagnostic paracentesis to exclude spontaneous bacterial peritonitis 1
  • Start empiric antibiotics if infection strongly suspected 1

Step 4: Obtain Urine Microscopy

  • Muddy brown casts or renal tubular epithelial cells indicate ATN 6
  • Bland sediment supports prerenal AKI or HRS 1
  • Microscopy significantly improves prognostic accuracy beyond clinical assessment alone 6

Step 5: Assess Response at 48 Hours

  • Full response: creatinine returns to within 0.3 mg/dL of baseline - confirms prerenal AKI 1
  • No response or progression: suggests ATN, HRS, or other intrinsic kidney disease 1
  • If no response and creatinine ≥1.5 mg/dL in cirrhosis, consider vasoconstrictor therapy (terlipressin or norepinephrine) plus albumin for HRS-AKI 1

Critical Pitfalls to Avoid

  • Do not rely solely on FeNa if diuretics were given - obtain FEUrea instead 3, 4
  • Do not assume low FeNa always means prerenal - early ATN and HRS can also show FeNa <1% 1, 5
  • Do not overlook timing - FeNa measured early in AKI course may be falsely low and convert to high values within days 5
  • Do not give excessive albumin without monitoring - pulmonary edema is a life-threatening complication 1
  • In cirrhosis, do not use FeNa alone for diagnosis - it has poor specificity and FEUrea is superior 1

Prognosis

  • Patients with prerenal AKI who respond to volume expansion have better outcomes than those with ATN 6
  • Even after "recovery," all AKI survivors remain at increased long-term risk for recurrent AKI, CKD progression, cardiovascular events, and mortality 1
  • Close follow-up is mandatory: check creatinine every 2-4 days during hospitalization and every 2-4 weeks for 6 months post-discharge 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mechanism of Low FENa in Prerenal Acute Kidney Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis.

Clinical journal of the American Society of Nephrology : CJASN, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.